Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CSER _CC_NCGL, |
RCV000148755 | SCV000190492 | uncertain significance | Thrombophilia due to protein S deficiency, autosomal dominant | 2014-06-01 | criteria provided, single submitter | research | Low GERP score may suggest that this variant may belong in a lower pathogenicity class |
Labcorp Genetics |
RCV001850018 | SCV002186373 | uncertain significance | Thrombophilia due to protein S deficiency, autosomal recessive | 2022-06-14 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with histidine, which is basic and polar, at codon 583 of the PROS1 protein (p.Asn583His). This variant is present in population databases (rs139479630, gnomAD 0.02%). This missense change has been observed in individual(s) with PROS1 deficiency (PMID: 15712227, 22627591). ClinVar contains an entry for this variant (Variation ID: 161349). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change does not substantially affect PROS1 function (PMID: 15712227). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002478415 | SCV002794267 | uncertain significance | Thrombophilia due to protein S deficiency, autosomal dominant; Thrombophilia due to protein S deficiency, autosomal recessive | 2022-02-17 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815209 | SCV005068861 | uncertain significance | Retinal dystrophy | 2022-01-01 | criteria provided, single submitter | clinical testing |